PRESSEMITTEILUNGEN

Düsseldorf (ots) – The rating agency Standard & Poor’s has today confirmed the current rating of BB+ for the Gerresheimer Group and continues to categorize the outlook as stable. The focus of the MDAX company on the pharma & life science industry is therefore assessed as positive and sustainable by the rating agency.

About Gerresheimer

Gerresheimer employs around 10,000 people in 42 locations in Europe, America and Asia. In the financial year 2008, worldwide sales totalled ?1.06bn. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery systems for the pharma & life science industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterized by high technical and regulatory barriers.

Contact Press

Burkhard Lingenberg
Director Corporate Communication & Marketing
Phone +49 211 6181-250
Fax +49 211 6181-241
e-mail b.lingenberg@gerresheimer.com

Contact Investor Relations
Anke Linnartz
Director Corporate Investor Relations
Phone +49 211 6181-314
Fax +49 211 6181-121
e-mail a.linnartz@gerresheimer.com

Trackback URL

Asia, Bb, Communication Marketing, Contact Press, Corporate Communication, Corporate Investor Relations, Corporate Marketing, Director Marketing, Drug Delivery Systems, E Mail, Gerresheimer, Life Science Industry, Pharma, Portfolio Ranges, Product Portfolio, Regulatory Barriers, Vials, Worldwide Sales